Dr. Stephen Paul Stewart, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2265 Bagnell Dam Blvd, Siute 103, Lake Ozark, MO 65049 Phone: 573-365-8800 Fax: 573-365-6011 |
Dr. Richard Kimball, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2265 Bagnell Dam Blvd, Ste 103, Lake Ozark, MO 65049 Phone: 573-365-6800 Fax: 573-365-6011 |
Kathleen M Robbins, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2265 Bagnell Dam Blvd, Ste 103, Lake Ozark, MO 65049 Phone: 573-964-5599 Fax: 573-365-6011 |
Debra A Atkinson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1870 Bagnell Dam Blvd, Lake Ozark, MO 65049 Phone: 573-365-2318 Fax: 573-365-3009 |
Dr. Virginia A Nagy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1870 Bagnell Dam Blvd, Lake Ozark, MO 65049 Phone: 573-365-2318 Fax: 573-365-3009 |
Dr. Jeffrey L Piontek, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1870 Bagnell Dam Blvd, Lake Ozark, MO 65049 Phone: 573-365-2318 Fax: 573-365-3009 |
News Archive
Purdue University and USDA-Agricultural Research Service scientists have discovered that a type of gene in grain-producing plants halts infection by a disease-causing fungus that can destroy crops vital for human food supplies.
Chemists at Johannes Gutenberg University Mainz (JGU) have developed a new method for parallel protein analysis that is, in principle, capable of identifying hundreds or even thousands of different proteins. It could be used to detect the presence of viruses and identify their type in tiny samples. At the same time, it is very cost-effective and quick.
Osaka University-led researchers identified differences in how three drugs bind to tumor necrosis factor, a key mediator of inflammatory disease. The team used sedimentation velocity analytical ultracentrifugation to investigate drug-target binding in a physiological environment and at clinically-relevant concentrations.
UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.
Fentanyl is a synthetic opioid so potent that a miniscule amount equivalent to several grains of salt can cause a fatal overdose. Yet it's difficult for people who use drugs to detect, which presents a major public health hazard given how commonly fentanyl is used to lace heroin or cocaine.
› Verified 5 days ago